Jamjoom Pharma Approves SAR 140M Dividend for H1 2025
Riyadh, Saudi Arabia — Jamjoom Pharma’s Board approved a 20% cash dividend for H1 2025, totaling...
Read More
Author: Hamad
Jamjoom Pharma Q2 Profit Rises 23% on Strong Regional Sales
Riyadh, Saudi Arabia — Jamjoom Pharma’s net profit rose 23.4% in Q2 2025 to SAR 132.02 million, up...
Read More
Electrical Industries Q2 Profit Jumps 36% on Strong Demand
Riyadh, Saudi Arabia — Electrical Industries Company (EIC) reported a 36% rise in Q2 2025 net...
Read More
Saudi Ceramic Swings to SAR 112M Profit in Q2 on Insurance Gain
Riyadh, Saudi Arabia — Saudi Ceramic Company returned to profitability in Q2 2025, reporting a net...
Read More
Saudi Arabia Privatizes First 3 Sports Clubs Under Vision 2030
Riyadh, Saudi Arabia — The Ministry of Sports, in cooperation with the National Center for...
Read More